- Therapeutic management of ALK+nonsmall cell lung cancer patients
Boris Duchemann et al, 2015, European Respiratory Journal CrossRef - Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer
Helen Chow et al, 2015, Journal of Thoracic Oncology CrossRef - Assessment of ALK gene fusions in lung cancer using the differential expression and exon integrity methods
QING HUANG et al, 2016, Oncology Letters CrossRef - Management of ceritinib therapy and adverse events in patients with ALK -rearranged non-small cell lung cancer
Raffaele Califano et al, 2017, Lung Cancer CrossRef - Evaluating the effectiveness of RNA in‐situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement
Naoki Nakajima et al, 2017, Histopathology CrossRef - ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice
Paul Hofman, 2017, Cancers CrossRef - Real-World Data on Treatment Outcome of ALK-Positive Non-Small Cell Lung Cancer from an Indian Multicentric Cancer Registry
Lalatendu Moharana et al, 2024, South Asian Journal of Cancer CrossRef - Targeting EP4 downstream c‐Jun through ERK1/2‐mediated reduction of DNMT1 reveals novel mechanism of solamargine‐inhibited growth of lung cancer cells
Yuqing Chen et al, 2017, Journal of Cellular and Molecular Medicine CrossRef - Crizotinib
Giuseppe Tridente, 2017, Adverse Events and Oncotargeted Kinase Inhibitors CrossRef - pH-sensitive polymeric nanocarriers for antitumor biotherapeutic molecules targeting delivery
Jiayi Qin et al, 2021, Bio-Design and Manufacturing CrossRef